Teg Hemostasis System 07-012
Teg Hemostasis System 07-012 is a Class II device made by Haemonetics Corporation, cleared under FDA 510(k) K002177 on 14 Sep 2000 (1 earlier submission) and listed in FDA GUDID since 31 Jul 2017 (UDI-DI 10812747018043), active as of 23 Oct 2026. 7 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10812747018043 | Date31 Jul 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK002177 | Date14 Sep 2000 | StatusActive |
Official records
- AccessGUDID record 10812747018043
- FDA 510(k) database K002177
- FDA 510(k) database K993678
Across registries
- FDA 510(k) K002177 decided 14 Sep 2000 Active
- FDA GUDID UDI-DI 10812747018043 listed 31 Jul 2017 Listed
Recalls
-
- Terminated Z-1310-2022
Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.
-
- Terminated Z-1298-2022
When the TEG 5000 Analyzer including TEG Analytical Software is used with PlateletMapping (ADP or AA) Assays and TEG Mangement Software, incorrect values of the PlateletMapping ADP or AA % Inhibition and % Aggretagion may be displayed on TEG Manager for the affected assays.
-
- Terminated Z-1617-2020
Software defect in TEG Manager impacts the displayed alert for out of range test results. Due to this defect, reference range values received from TEG 5000 and displayed on the TEG Manager test result screen are rounded to the nearest whole number and lead to TEG Manager displaying an out of range alert when the test result is actually in range, or vice versa.
-
- Terminated Z-1130-2015
Specific lots of Level II Control Kits produce high Maximum Amplitude (MA) results, which are outside of the manufacturer's expected Quality Control range for MA parameter.
-
- Terminated Z-1796-2013
Research Use Only (RUO) parameters were included in TEG 5000 User Manual.
-
- Terminated Z-2742-2011
Haemoscope received a report that during the process of Validation, Level II QC was running with an out-of-range low MA (Maximum Amplitude).
-
- Terminated Z-1738-2011
Haemonetics has received a report of smoke from the unit with a power supply failure.
Timeline
- Cleared FDA 510(k) K993678
- Cleared FDA 510(k) K002177
- Recall initiated FDA recalls Z-1738-2011
- Recall initiated FDA recalls Z-2742-2011
- Recall initiated FDA recalls Z-1796-2013
- Recall initiated FDA recalls Z-1130-2015
- Listed FDA GUDID 10812747018043
- Recall initiated FDA recalls Z-1617-2020
- Recall initiated FDA recalls Z-1298-2022
- Recall initiated FDA recalls Z-1310-2022
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Teg Hemostasis System
- Generic name
- Calcium chloride coagulation reagent IVD
- Model / reference
- 07-012
- Primary DI / UDI-DI
- 10812747018043
- FDA product code
- JPA
- GMDN term
- Calcium chloride coagulation reagent IVD
- Device class
- Class II
- Regulation number
- 864.5425
- GUDID distribution status
- In Commercial Distribution
- Size
- Total Volume — 5 Milliliter